IGF1 and metabolic dysfunction-associated steatotic liver disease: No difference in IGF-1 receptor or GH receptor gene expression across worsening stages of NAFLD/NASH compared to that in control↓ IGF-1 gene expression across disease stagesNo difference in GH receptor staining intensity by the severity of NAFLD compared to that in the control group